BillionToOne

Menlo Park, United States

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

Jun 2024

Series D

Top Investors

Norwest500 GlobalY CombinatorHummingbird VenturesHOF Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are BillionToOne's investors?

BillionToOne's investors include Norwest, 500 Global, Y Combinator, Hummingbird Ventures, HOF Capital.

Where is BillionToOne headquartered?

BillionToOne is headquartered in Menlo Park, United States.

What does BillionToOne do?

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

What stage is BillionToOne at?

BillionToOne is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 21, 2024.

MLA

"BillionToOne — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/billiontoone. Accessed July 1, 2026.

APA

VCBacked. (2024). BillionToOne — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/billiontoone

Wikipedia (cite web)

{{cite web |title=BillionToOne — Funding & Investors |url=https://www.vcbacked.co/company/billiontoone |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 21, 2024.